Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effectiveness and safety in double-blind,
randomized, placebo-controlled clinical trials of self administered PH80 intranasal spray for
the acute management of cycle related symptoms in women who regularly experience premenstrual
dysphoric disorder (PMDD).